Drag Pharma

Ursovet®

Treatment of inflammatory hepatobiliary diseases that cause hepatobiliary cholestasis

Ursovet® oral suspension is indicated for the treatment of inflammatory hepatobiliary diseases that cause hepatobiliary cholestasis in dogs and cats. Due to its choleretic, cytoprotective and immunomodulatory properties, its use is useful in cases of chronic hepatitis, cholangitis, cholangiohepatitis and cases of cholestasis that do not present with biliary obstruction.

Data Sheet

Oral suspension.

Treatment of inflammatory hepatobiliary diseases.

Dogs and cats.

Each 1 mL of oral suspension contains:
Ursodeoxycholic acid……….50 mg
Excipients c.s.p………………….1 mL

Ursovet® oral suspension is indicated for the treatment of inflammatory hepatobiliary diseases that cause hepatobiliary cholestasis in dogs and cats. Due to its choleretic, cytoprotective and immunomodulatory properties, its use is useful in cases of chronic hepatitis, cholangitis, cholangiohepatitis and cases of cholestasis that do not present with biliary obstruction.

Orally.

10 to 15 mg/Kg, every 24 hours or divided every 12 hours.

  • Dogs: 2 to 3 mL per 10 kg of body weight, every 24 hours or divided every 12 hours.
  • Cats: 0.2 to 0.3 mL per kg of body weight, every 24 hours or divided every 12 hours.

It is recommended that treatment be administered 3 to 4 months after the patient has shown improvement in the biochemical markers indicative of liver pathology.

  • Do not use in patients who present biliary obstruction, fistula, pancreatitis or other complications associated with cholelithiasis.
  • Do not use in patients with known hypersensitivity to bile acids.
  • Do not use in rabbits or other colonic fermenting species. In these species Ursodeoxycholic Acid is converted to Lithocholic acid (toxic).
  • Special caution should be taken in patients with chronic liver disease, as they may have greater difficulty metabolizing bile acids.
  • Do not use in pregnant or lactating females.
  • In rare cases, there may be episodes of vomiting and/or diarrhea. In this case, discontinue use and consult your Veterinarian.
  • In the event of an overdose, it is recommended to perform gastric emptying, or the administration of activated charcoal or an antacid containing aluminum.
  • Keep away from the reach of children and pets.
  • Wash your hands after administering the product.

Antacids containing Aluminum or Cholestyramine resin can bind Ursodeoxycholic Acid, reducing its effectiveness.

Discard unused product remains in their original packaging. Do not throw the empty container or product residue into rivers, lakes or streams of water. Do not reuse the container. Dispose of waste from this product, if possible, in suitable places where special waste is disposed of.

  • Store at room temperature, between 15 and 30 °C.
  • Once opened, use the product within 3 months. Discard unused product after that period of time.

Sale under Veterinary Medical prescription.

VETERINARY USE
SHAKE BEFORE USE

Chile: Reg. SAG N° 2034
Costa Rica: Reg. N° MV-6133
Uruguay: Reg. MGAP: 2018A00569
Perú: Reg. SENASA F.G7.02.I.0001
Bolivia: Reg. SENASAG PUV-Nº 009798/21

Bottle with 60 mL

Laboratorio Drag Pharma Chile Invetec S.A.
Lautaro N° 300 • Quilicura • Santiago • Chile

SKU: 41bfd20a38bb Category: Tags: , , , , ,
*Important:

You have accessed information referring to pharmaceutical products authorized for sale under a medical prescription. In accordance with Chilean legislation, the promotion and advertising of these products is restricted to professionals who prescribe and dispense them. The information contained on this page is specialized technical and scientific information.